lisdexamfetamine dimesylate
Generic: lisdexamfetamine dimesylate
Labeler: rhodes pharmaceuticalsDrug Facts
Product Profile
Brand Name
lisdexamfetamine dimesylate
Generic Name
lisdexamfetamine dimesylate
Labeler
rhodes pharmaceuticals
Dosage Form
CAPSULE
Routes
Active Ingredients
lisdexamfetamine dimesylate 60 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
42858-166
Product ID
42858-166_047c243d-9336-4ef2-b5a8-a7cae312b1be
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA215330
DEA Schedule
cii
Listing Expiration
2026-12-31
Marketing Start
2024-01-30
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
42858166
Hyphenated Format
42858-166
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
lisdexamfetamine dimesylate (source: ndc)
Generic Name
lisdexamfetamine dimesylate (source: ndc)
Application Number
ANDA215330 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 60 mg/1
Packaging
- 100 CAPSULE in 1 BOTTLE, PLASTIC (42858-166-01)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "047c243d-9336-4ef2-b5a8-a7cae312b1be", "openfda": {"unii": ["SJT761GEGS"], "rxcui": ["854830", "854834", "854838", "854842", "854846", "854850", "1593856"], "spl_set_id": ["d918b40d-a461-41bc-b6c0-83dc76c28e32"], "manufacturer_name": ["Rhodes Pharmaceuticals"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE, PLASTIC (42858-166-01)", "package_ndc": "42858-166-01", "marketing_start_date": "20240130"}], "brand_name": "LISDEXAMFETAMINE DIMESYLATE", "product_id": "42858-166_047c243d-9336-4ef2-b5a8-a7cae312b1be", "dosage_form": "CAPSULE", "pharm_class": ["Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]"], "product_ndc": "42858-166", "dea_schedule": "CII", "generic_name": "LISDEXAMFETAMINE DIMESYLATE", "labeler_name": "Rhodes Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "LISDEXAMFETAMINE DIMESYLATE", "active_ingredients": [{"name": "LISDEXAMFETAMINE DIMESYLATE", "strength": "60 mg/1"}], "application_number": "ANDA215330", "marketing_category": "ANDA", "marketing_start_date": "20240130", "listing_expiration_date": "20261231"}